Clinical Lung Cancer : Impact Factor & More
eISSN: 1938-0690pISSN: 1525-7304
Share this on:
Aims and Scope of Clinical Lung Cancer
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Clinical Lung Cancer
Clinical Lung Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Lung Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Lung Cancer
Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State.
- 1 May 2026
- Clinical lung cancer
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?
- 1 May 2026
- Clinical lung cancer
Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies.
- 1 May 2026
- Clinical lung cancer
Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma.
- 15 Apr 2026
- Clinical lung cancer
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib: A Case Report.
- 11 Apr 2026
- Clinical lung cancer
Staging Modalities in Non-Small Cell Lung Cancer: Evidence-Based Guideline and Systematic Review by the Brazilian Group of Thoracic Oncology.
- 10 Apr 2026
- Clinical lung cancer
Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State.
- 1 May 2026
- Clinical lung cancer
To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?
- 1 May 2026
- Clinical lung cancer
Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies.
- 1 May 2026
- Clinical lung cancer
Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma.
- 15 Apr 2026
- Clinical lung cancer
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib: A Case Report.
- 11 Apr 2026
- Clinical lung cancer
Staging Modalities in Non-Small Cell Lung Cancer: Evidence-Based Guideline and Systematic Review by the Brazilian Group of Thoracic Oncology.
- 10 Apr 2026
- Clinical lung cancer
FAQs on Clinical Lung Cancer
How long has Clinical Lung Cancer been actively publishing? 
What is the publishing frequency of Clinical Lung Cancer?
How many articles did Clinical Lung Cancer publish last year?
What is the eISSN & pISSN for Clinical Lung Cancer?
What is Citescore for Clinical Lung Cancer?
What is SNIP score for Clinical Lung Cancer?
What is the SJR for Clinical Lung Cancer?
Who is the publisher of Clinical Lung Cancer?
